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ABSTRACT 
Body odour caused by bacterial growth is of great concern to those affected. To ameliorate this, deodorants, which are substances applied to 
avert body odour, are designed and used. These deodorants are claimed to have antibacterial activities. This work was therefore, carried out to 
determine the antibacterial activities of the deodorants marketed in Owerri municipality. Owerri is the capital of Imo State of Nigeria. To 
determine this, twenty (20) deodorants from ten (10) different manufacturers made up of fourteen (14) roll-on and six (6) sprays were assessed 
using punch -hole plate diffusion technique on nutrient agar plates. The deodorants were purchased from Ekeonunwa market, New market, 
Relief market, and some supper markets, all in Owerri Municipality. These deodorants were tested against Laboratory isolates of 
Staphylococcus epidermidis, Pseudomonas aeruginosa, Escherichia coli and Proteus mirabilis obtained from Federal Medical Centre (FMC) and 
Modesty Medical Laboratory Owerri and reconfirmed using morphological and biochemical tests. Out of the twenty (20) deodorants tested, 18 
(90%) were active against the organisms, 17 (85%) were active against  Staphylococcus epidermidis, 15 (75%) against P. mirabilis, 11 (55%) 
against E. coli and 10 (50%) against P. aeruginosa. It was also observed that deodorants  “roll - on” were more active  14 (100%) than the 
deodorants “sprays” 4 (66.6%). From this study, it was observed that the deodorants tested had antibacterial activities. 





Deodorants  are substances applied to the body to affect 
body odour  caused by bacteria growth and the smell 
associated with bacterial breakdown of perspiration in 
armpits, feet and other body areas1. A sub group of 
deodorants, ‘antiperspirants’, affect odour as well as prevent 
sweating by affecting sweat glands. Antiperspirants are 
typically applied to the underarms, while deodorants may 
also be applied on the feet and other areas in the form of 
body sprays2. 
Human perspiration is largely odourless until it is fermented 
by bacteria that thrives in hot, humid environments3. The 
human underarm is among the most consistently warm 
areas on the surface of the human body, and sweat  glands 
provide moisture, which when excreted, has a vital cooling 
effect. When adult armpits are washed with alkaline PH soap, 
the skin loses its acid mantle (PH 4.5 - 6), raising the skin PH  
and disrupting the skin barrier4. Many bacteria thrive in this 
elevated   PH environment5. These bacteria feed on the sweat 
from the apocrine glands and on dead skin and hair cells, 
releasing  trams -3 – methyl - 2- hexenoic acid in their waste 
which is the primary cause of body odour6. Underarm hair 
wicks the moisture away from the skin and aids in keeping  
the skin dry enough to prevent or diminish bacterial 
colonization. The hair is less susceptible to bacterial  
 
growth and therefore is ideal for preventing the bacterial 
odour7. While deodorants, reduce body odour by killing the 
odour causing bacteria, they do  not affect the amount of 
perspiration the body produces. Antiperspirants, on the 
other hand inhibit the activity of sweat glands, so less 
moisture is produced in addition to avoiding unpleasant 
wetness. These products  also decrease odour because there 
are less sweat for the bacteria to act upon8. 
The terms ‘deodorants’ and “antiperspirants” are often used 
interchangeably, although they describe two different 
products. While the most frequent active ingredient in 
commercial antiperspirants are Aluminium chlorohydrate 
and Aluminium zirconium tetrachorohydrate gly, 
deodorants are usually alcohol-based, containing some anti-
microbial agents such as Fernesole, triclosan, Paraben, Zinc 
riconoleate, trieltyl citrate, chlorophyllin copper complex 
and other metal, chalent compounds that slow bacterial 
growth 9, 10, 11. 
Deodorants exhibit their antimicrobial activities, by reducing 
the body  PH  which in turn inhibits the growth of micro-
organisms  that produce malodour12. Another difference 
between deodorants and antiperspirants is that, while 
deodorants are considered to be cosmetics products because 
they only control odour, antiperspirants are actually drugs 
because they affect the physiology of the body13. The first 
ever deodorant was produced by zingal in the 9th Century in 
Al-Andalus14. Ever since then modernizations have been 
going on, with some criticisms from the US food and Drug 
Administration (FDA) and Environmental  protections 
Agency (EPA) which brought about what we now have in 
the market as present day deodorants.  
Deodorants and antiperspirants come in many forms. What 
is commonly used, varies from country to country. In 
Europe, aerosol sprays are popular, as are cream and roll-on 
forms. In the United State, solid or gel forms are dominant. 
And in Nigeria (especially Owerri), both the sprays and the 
roll-on brands are common. Many people use and believe in 
the antibacterial effectiveness of these deodorants, which 
they hope will prevent or reduce the body odour.  
This work therefore, was carried out to determine the 
antibacterial effect of these deodorants marketed in Owerri, 
the capital of Imo State of Nigeria.  
It is also aimed at comparing the level/degree of efficacy 
between the two brands marketed in Owerri. 
 
MATERIALS AND METHODS 
ORGANISM 
The organisms used were laboratory isolates such as 
Staphylococcus epidermidis, (skin normal flora) Preteus 
mirabilis, Pseudomonas aeruginosa and Escherichia coli which 
were obtained from Federal Medical Center Owerri (FMC) 
and Modesty Medical Laboratory Owerri in Imo State of 
Nigeria from June – November 2011. The organisms were 
tested, using standard discs and were found to have zones of 
inhibition of more than 15 mm diameter against pencillin, 
ampicillin, gentamycin and ampicillin respectively. 
 
These isolates were reconfirmed before being used in this 
research work.  The reconfirmation was done in Modesty 
Medical Laboratory following the conventional method of  
identification such as Morphological,  Grams staining 
reaction technique, Motility and Biochemical methods. 
 
PREPARATION OF DEODORANT 
A total of twenty (20) deodorants from ten (10) different 
manufacturers were tested. They were made up of fourteen 
roll-ons (R1-R14) and six sprays  (S1-S6).The deodorants were 
selected randomly. The fluid of each deodorant roll-on, was 
aspirated aseptically into sterile tubes. 
While that of the spray was sprayed into a sterile  container 
before been used for this work.  
SUSCEPTIBILITY TESTING 
Plate diffusion technique using the punch-hole method was 
adopted, oxoid nutrient agar medium which was used was 
prepared and sterilized according to the manufacturer’s 
instruction. The nutrient agar plates were inoculated with 
the bacteria, each plate for each bacterium but was done in 
duplicate. 
The plates were inoculated with the organism after dilution 
to give about 106 cells/ml. Punch holes were made using 
sterile cock borer of 10mm diameter. Each hole was labelled 
against the deodorant and filled, allowed to stay for about 
30minutes before incubation at 370C for 18hours. Zones of 
inhibition were measured using mm ruler. Any deodorant 
giving an inhibition zone of more than 2mm on either side of 
the hole was regarded as having antibacterial activity.    
RESULTS 
The antibacterial activities of twenty (20) deodorants from 
ten (10) different manufacturers consisting of fourteen (14) 
roll-ons and six (6) sprays were assessed using agar diffusion 
16 
 
punch - hole technique against  Staphylococcus epidermidis, 
(skin normal flora), Proteus mirabilis, Escherichia coli and 
Pseudomonas.aeruginosa. Diameter of the zones of inhibition 
was measured. Zones less than 2mm on either sides of the 
hole were considered resistant. 
 Out of the twenty (20) deodorants that were tested against 
the organisms, 18 (90%) have zones of inhibition greater than 
2mm on each side. Seventeen 17 (85%) showed antibacterial 
activity against S. epidermides, fifteen 15 (75%) inhibited P. 
mirabilis. Eleven 11 (55%) was active against E. coli and 10 
(50%) inhibited P. aerugenosa. 
All the deodorants that were active against S. epidermides 
showed zones of inhibition above 5mm, except R4, R14, S1 and 
S2 that had 2mm zones of inhibition each and R11 showed the 
highest zone of inhibition (15mm) against S. epidermidis. 
 P. aerugenosa was the least sensitive of all the organisms to 
the deodorants, 10 (50%). Out of the ten deodorants that 
were active against it, R8 and R10 showed the highest zone of 
inhibition 13mm each.   
 
Among the fourteen (14) roll-on deodorants assessed, eleven 
11 (78.6%) showed zones of inhibition against all the 
organisms, fourteen 14 (100%) were active against S. 
epidermides, ten 10(71.4%) against P. aerugenosa, Eleven 11 
(78.6%) against  E.coli  and fourteen 14 (100%) against P. 
mirabilis.  Comparing the six (6) spray deodorants assessed, 
none (0%) was active against all the organisms, but 3 (50%) 
were active against S. Epidermides, two 2 (33.3%) against P. 




This work aimed primarily to determine the antibacterial 
activities of different brands of deodorants marketed in 
Owerri  metropolis of Imo State, Nigeria, as well as 
comparing the level/degree of efficacy between the two 
brands marketed   in Owerri 
The deodorants roll-on, R11, R8,  and R10  were discovered to 
have higher level of activity to all the four tested organisms 
with {(15,8,10,15), (14,13,15,14), and (13,13,13,12)} mm 
diameter respectively. This peculiar high levels of zones of 
inhibition reveals the antibacterial efficacies of their various 
active ingredients (such as triclosan, fanesole, paraben, 
triethyl citrate and so on). Such level of antimicrobial activity 
is desirable in the production of deodorants15, and 
possession of acceptable level of antimicrobial activity by 
super critical Hops extract have been used as natural 
deodorants16. 
 
R4, R13,  and R14 on the other hand showed no zone of 
inhibition to some of the organisms {(2,0,0,4) (9,0,0,6) and 
(2,0,0,2)} mm diameter respectively. This could mean that 
their various active ingredients are contained in low 
concentrations. This is proven by the statement that some 
bacterial species can develop low level resistance to triclosan 
at its low bacteriostatic concentrations due to Fable 
mutations which results in a decrease to triclosan’s effect on 
ENR-NAD + binding17,18. 
 
Considering  sprays, only four sprays (S1, S2, S4,S5) showed 
zones of inhibition to some of the organisms  and among the 
four sprays that showed the zones of inhibition, only S5  
showed appreciable zone of 6mm diameter to two of the 
organisms, others showed zones less than 3mm diameter 
each to one of the organisms only. This may be attributed to 
the fact that their various active ingredients are contained in 
very low concentration, regardless of the fact that they were 
listed on the containers of the sprays in their right 
proportions. This is in agreement with 19 who stated that 
‘Another way for these bacteria to gain low-level resistance 
to triclosan is to over express fable because some bacteria 
have innate resistance to triclosan at low bacteriostatic level.  
Again, the proportion of the ingredients may be in their  
right order, but, because they are in their gaseous states, they 
do not have long time of contact with the organisms before 
they evaporate, thereby bringing the concentration in contact 
with the organism lower than what it should be. This is also 
in agreement with19.  
 
Then, looking at the susceptibilities of the test organisms 
used, the high level of susceptibility  shown by 
Staphylococcus epidermidis (85%) could be related to the fact 
the organism is a normal flora of the skin which is the 
primary target of deodorants production. Staphylococcus 
along side with Corynebacterium and Propionibacterium were 
listed as the notable bacterial skin normal flora20. 
Pseudomonas aerugenosa showed the lowest susceptibility 
(50%) to all the deodorants tested. Some of deodorants tested 
were found to have (0%) activeness against it. This could be 
because P. aerugenosa posses multi-drug efflux that pumps 
triclosan out of the cells21,22. 
CONCLUSION AND RECOMMENDATIONS 
In conclusion, we confirm that Deodorants in Owerri market 
are active against bacterial growths associated with 
breakdown of perspiration in armpits, feet, and other areas 
of the body to produce body odour.  
We therefore recommend the use of deodorants to control 
the body odour caused  by bacterial breakdown of lipid and 
protein in sweat, especially during the Adolescent and adult 
stages of life, when the apocrine gland is developed and 
produces sweat rich in protein and fatty acid.  
We also recommend to the manufacturers, that enough 
active ingredients be added in the production of different 
brands of deodorants to enable them achieve their primary 
aim of production.  
Finally we recommend that the National Agency for Food 
and Drug Administration and Control (NAFDAC) and the 
Consumers Protection Council  (CPC) should rise up to their 
responsibility of ensuring that the ingredient listed on the 
containers of these deodorants and their concentrations  are 
actually corresponding to their real contents to avoid 
deceiving the poor masses. Also further monitoring 















Fig 1:  Shows each deodorant  and number of organisms affected. 
Key: R1.......... R14  = Roll on brands of deodorants (1-14); S1.......... S6    = spray brand of deodorants (1- 6) 
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